News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
09 27 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2022 financial results on Thursday, October...
-
09 15 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Lee Health, Southwest Florida's primary community-owned health system, are teaming up to enhance...
09 08 2022 Our Media Statement about COVID-19 Testing This is an evolving situation. Please check back to this page periodically for the latest information For more information, members of the media may...
-
09 08 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global...
-
09 07 2022 First lab-developed test specifically designed to detect Monkeypox virus DNA to receive emergency use authorization during the monkeypox public health emergency SECAUCUS, N.J., Sept. 7, 2022...
-
08 17 2022 New test panel follows a Quest Diagnostics Health Trends® study with the CDC that revealed less than half of pregnant people are screened for hepatitis C as recommended under guidelines SECAUCUS,...
-
08 10 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
-
08 05 2022 The American Heart Association Hispanic Serving Institutions Scholars program supports priority diversification in the pipeline of healthcare professionals with the support of the Quest DiagnosticsDALLAS, August 5, 2022 — The American Heart Association, the world’s leading nonprofit organization focused on longer, healthier lives for all, is committed to addressing the lack of diversity...
08 04 2022 Better healthcare among America's large and growing Hispanic community is receiving an important, new level of support from Quest Diagnostics, the world's leading provider of diagnostic...
-
08 03 2022 SECAUCUS, N.J., (August 3, 2022) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized by Forbes as one of America’s...
07 27 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for...
-
07 25 2022 Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients Findings heighten...
-
07 21 2022 Second quarter revenues of $2.45 billion, down 3.8% from 2021 Second quarter reported diluted earnings per share ("EPS") of $1.96, down 60.5% from 2021; and adjusted diluted EPS of $2.36, down...
-
07 19 2022 Testing available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with appointment; at all other Rite Aid locations customers can schedule to pick up at-home specimen collection kits for PCR testingPHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing...
-
07 13 2022 Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response Physicians can order the novel Quest Diagnostics lab test beginning today...
07 11 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today released its 2021 Corporate Responsibility Report. The report provides information regarding...
-
07 07 2022 Qualified uninsured individuals now have access to the company's COVID-19 molecular diagnostic testing at approximately 1,200 Quest Diagnostics patient service centers SECAUCUS, N.J., July 7, 2022...
-
06 24 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2022 financial results on Thursday, July...
-
06 14 2022 Leading Patient Engagement Platform Honored in Digital Therapeutics and Mental Health Category BIRMINGHAM, Ala., June 14, 2022 /PRNewswire/ -- Leading patient engagement platform Pack Health, a...
-
06 13 2022 Nationally representative study of more than 5 million pregnant people finds those with Medicaid less likely to be screened than those with commercial insurance, demonstrating disparities in...
06 09 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sam Samad will become Executive Vice President and Chief Financial Officer. He...
-
06 06 2022 Analysis shows participants who stayed in the program at least 6 months reduced their diabetes drug costs by 18% In 2 oral and 3 poster presentations, Quest researchers also provided insights into...
-
05 31 2022 ConferMED, one of the nation's leading eConsult companies, has been awarded a $2.3M grant from the Quest Diagnostics Foundation. The grant will enable ConferMED to enhance its eConsults platform...
-
05 26 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Healthcare Conference. Steve...
05 25 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Cecilia McKenney, Senior Vice President and Chief Human Resources Officer (CHRO),...
-
05 17 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
-
05 11 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS 2022 Global Healthcare Conference....
-
05 09 2022 "2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health...
-
05 02 2022 Blood Test for Early Detection of Alzheimer's Disease (AD) Risk Will Lead to Better Patient Care, Physicians Say; U.S. Adults Call for Earlier Evaluation and More Education Quest Introduces Widely...
-
04 21 2022 First quarter revenues of $2.61 billion, down 4.0% from 2021 First quarter reported diluted earnings per share ("EPS") of $2.92, down 15.6% from 2021; and adjusted diluted EPS of $3.22, down 14.4%...
-
04 20 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has made several organizational changes and leadership appointments of seasoned...
-
04 04 2022 New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Site Builds on Quest's Extended Care Services to Improve...
-
03 30 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2022 financial results on Thursday, April...
03 30 2022 Positivity for Cocaine and Marijuana Increase for Federally Mandated, Safety-Sensitive Workers Required to Test Under Federal Law Amid Widespread Recruiting and Retention Challenges, Drug...
-
03 23 2022 Quest to employ its comprehensive menu of COVID-19 antibody test and data analytics services to support population health research across 45 states and Puerto Rico SECAUCUS, N.J., March 23, 2022...
03 15 2022 The Quest Diagnostics Foundation today announced a $500,000 donation to Project HOPE to support its humanitarian crisis relief efforts in Ukraine and for Ukrainian refugees in Eastern Europe....
-
02 22 2022 At Quest Diagnostics, our vision is “Empowering better health with diagnostic insights.” Our goal is to make this a healthier world – not just for some, but for all. As we near the two-year...
02 15 2022 Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three statesBronx, N.Y./Secaucus, N.J, Feb. 15, 2022: Green Bronx Machine, a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences, today...
-
02 03 2022 -- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive ChairmanQuest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its Board of Directors, as part of its ongoing leadership succession planning,...
-
02 03 2022 - Full year revenues of $10.79 billion, up 14.3% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
-
02 02 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022...
-
01 31 2022 Convenient, physician-guided medical insights help people manage health without a trip to the doctor's officeQuest Diagnostics (NYSE: DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to...
-
01 28 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a score of 100% on the Human Rights Campaign Foundation's 2022...
-
01 26 2022 The ELF™ Test is the first and only prognostic blood test granted De Novo marketing authorization to assess disease progression in NASH patients. The ELF Test is now available nationwide through collaborations with Labcorp and Quest Diagnostics.TARRYTOWN, N.Y.--(BUSINESS WIRE)--The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive...
-
01 26 2022 Quest Diagnostics to Support COVID-19 Testing for Illinois and Texas Long-Term Care Facilities’ Residents, StaffWASHINGTON, DC (Jan. 26, 2022) - Project HOPE, a global health and humanitarian organization, is pleased to announce that Quest Diagnostics (NYSE: DGX), the world’s leading provider of...
-
01 26 2022 Individuals may perform test in minutes in the comfort of their home, at their convenienceQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of an at-home COVID-19 rapid antigen test service for consumer...
-
01 19 2022 First-of-Its Kind Service Includes Robust Selection of Diagnostic Tests, Customizable for Men and Women, with Biometric Screening and a Health Risk Assessment to Provide a Health Quotient Score That Can Be Tracked Over TimeAdults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the...
-
01 18 2022 Acquisition adds new capability in "Extended Care" services focused on engaging patients beyond traditional healthcare settings to improve outcomes and lower costsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement to acquire Pack Health in an...
-
01 12 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the fourth quarter and full year...
-
01 11 2022 Quest Diagnostics to Release Fourth Quarter and Full Year 2021 Financial Results on February 3, 2022Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2021 financial results on...
-
01 04 2022 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 40th Annual J.P. Morgan Healthcare...
12 16 2021 Junior Achievement of New Jersey (JANJ) virtually held its 19th annual New Jersey Business Hall of Fame™ on Thursday, December 9, 2021. The 2021 Laureates included John E. Harmon, Sr., IOM,...
-
12 16 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2021 Workplace...
-
12 14 2021 Acquisition to broaden physicians' access to diagnostic services and deepen company's presence in the SoutheastQuest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has acquired substantially all assets of Labtech Diagnostics, an independent...
-
12 01 2021 Targeted Lung Panel Now Available with Physician's Order at Quest's 2,200 Patient Service Centers NationwidePhysicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics (NYSE: DGX), the nation's leading provider of...
-
11 17 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
-
11 15 2021 First-of-its-kind study reveals nearly three in four physicians believe telehealth visits limit the ability to determine if patients are at risk for or are already misusing prescription drugsA new Health Trends® report from Quest Diagnostics (NYSE: DGX) finds that almost 70% of physicians fear they missed signs of drug misuse during the pandemic, and, given how the global health...
-
11 08 2021 SECAUCUS, N.J., (DATE) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized as one of the World's Best Employers of...
-
11 04 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 30th Annual Healthcare...
-
11 04 2021 For the last twenty months, 50,000 Quest colleagues have given their all every day to support our nation through the COVID-19 crisis. The experience has shown the character of our company—and...
-
11 02 2021 Professional development program strives to eliminate health disparities among underserved populations by cultivating a pipeline of minority scholars for leadership roles in healthcareKANSAS CITY, MO, NOVEMBER 2, 2021 — The Bluford Healthcare Leadership Institute (BHLI), committed to eliminating health disparities among minority and vulnerable populations, recently hosted its...
-
10 21 2021 - Third quarter revenues of $2.77 billion, down 0.4% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2021. "We...
-
10 20 2021 Over 1,150 school districts in Texas can elect to participate in the testing programQuest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced it has formed an agreement with the Texas Department of State Health Services (DSHS)...
-
10 18 2021 As the First Laboratory to Validate Ki-67 IHC MIB-1 pharmDx (Dako Omnis), Quest Plans to Make Testing Available Nationally by the End of OctoberQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx...
10 12 2021 Advanced Technology and Automation Delivers Quality Lab Results to Physicians and Patients in Seven StatesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, has completed its integration of Northeast regional operations to its new 250,000 sq....
-
10 07 2021 Quest Diagnostics makes more than $3 million commitment to American Heart Association efforts to expand research and mentorship opportunities for Black and Hispanic scholars, and drive hypertension management and COVID-19 reliefDALLAS, October 7, 2021 — The American Heart Association (AHA), the leading public health nonprofit devoted to a world of healthier lives for all -- through a significant commitment from Quest...
-
10 05 2021 Onsite testing event will service more than 10,000 entrants, staff and volunteers to provide a safer environment for allThe Boston Athletic Association (B.A.A.) and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Quest will be the exclusive...
-
09 29 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2021 financial results on Thursday, October...
-
09 28 2021 Nationwide analysis of blood lead levels in children under six years of age finds ties between exposure, older homes, and poverty, and raceOne in two (50.5%) American children under six years of age tested have detectable levels of lead, a toxic metal, in their blood, according to a new Health Trends® study from Quest Diagnostics...
-
09 10 2021 Guests may schedule appointments for COVID-19 viral testing from Quest Diagnostics at 1,500 locations nationwideCarnival Corporation & plc (NYSE/LSE: CCL;NYSE: CUK), the world's largest cruise company, today announced a new initiative making pre-board testing more convenient and accessible for its guests....
-
09 09 2021 -- Revenues for full year 2021 now expected to be $9.84-$10.09 billion compared to the previous outlook of $9.54-$9.79 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2021. Since the company reported its...
-
08 31 2021 Nationwide analysis finds declines in the rate of new diagnoses of eight common cancers from March 2020-March 2021 versus prior to the pandemic suggesting a future wave of more advanced disease due to belated diagnoses
New diagnoses of eight common types of cancer (prostate, breast, colorectal, lung, pancreatic, cervical, gastric and esophageal) significantly declined during most of the first 13 months of the...
-
08 30 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 19th Annual Global...
-
08 24 2021 Physicians and patients to benefit from access to Quest’s industry-leading test menu and network of patient service centers throughout the stateSECAUCUS, N.J., and BOCA RATON, F.L. – August 24, 2021 – Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced it has acquired select assets of...
08 17 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director....
-
08 16 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
-
08 11 2021 Testing can be performed by individuals from the comfort of their home, at their convenience, to encourage compliance and limit exposure in an office setting. New testing option complements Quest's current return-to-work solutions featuring molecular diagnostic and antibody testingMIAMI and SECAUCUS, NJ, Aug. 11, 2021 (GLOBE NEWSWIRE) -- eMed™, a telehealth company democratizing healthcare through digital-point-of-care solutions, and Quest Diagnostics (NYSE: DGX), the...
-
08 04 2021 North Charleston, S.C. — Select Health of South Carolina and Quest Diagnostics announced they have entered into an agreement that expands Select Health’s laboratory network for its Medicaid...
-
07 29 2021 The clinic will offer integrated and multidisciplinary services for the care of patients who have suffered from COVID-19.Salud Integral en la Montaña, Inc., (SIM) will expand its range of primary medical care with the first Post COVID-19 Care Clinic in Puerto Rico. In this clinic, patients will have access to a...
-
07 22 2021 - Second quarter revenues of $2.55 billion, up 39.5% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2021. "We had...
-
07 20 2021 Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers and live event attendanceCLX Health, developer of cloud-based solutions to manage the COVID-19 testing ecosystem with their TrustAssure™ Global Network, today announced a collaboration with Quest Diagnostics (NYSE:...
07 14 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2021 Disability Equality Index® (DEI) Best Places to Work for...
-
07 12 2021 Tackle Your Testing program will kick off this summer with free health events across Florida to provide diagnostic testing, education, nutritious meals and more to empower people to take control of their health.Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services today announced the Tackle Your Testing program to address the health disparities...
-
07 06 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2021 financial results on Thursday, July...
06 21 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released the Annual Corporate Responsibility Report for 2020. Titled "A Year of...
-
06 01 2021 Physicians and patients will benefit from access to Quest's industry-leading test menu in Arkansas, Kansas, Missouri and OklahomaQuest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory services business of Mercy in an all-cash asset...
05 26 2021 First Large-Scale National Analysis of Workforce Drug Testing During the COVID-19 Pandemic, Based on More Than 9 Million Drug Tests in 2020The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce, according to a new analysis released...
-
05 25 2021 Goal to develop regulatory-approved software products and services based on AI-generated insights from Quest's digital pathology diagnostic dataQuest Diagnostics (NYSE:DGX) and Paige today announced a collaboration designed to unlock the potential of artificial intelligence (AI) to improve and speed the diagnosis of cancer and other...
-
05 24 2021 Collaboration utilizes digital content to educate children and inspire healthy outcomesChildhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years. In the wake of COVID-19, low-income and...
-
05 20 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.62 per share,...
-
05 19 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference....
-
05 11 2021 Eligibility for $0 out-of-pocket COVID-19 testing expanded to include adults and minors regardless of symptoms or suspected exposure, consistent with updated government guidance on insurance coverage for COVID-19 testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled several new enhancements to its COVID-19 testing services, with the goal to help...
-
05 11 2021 In the Largest Study of its Kind, Findings Highlight the Need to Increase Hepatitis C Testing and Treatment to Decrease Rates of Transmission, Morbidity, and MortalityA new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 pandemic reduced routine hepatitis C...
-
05 03 2021 Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools NationwideCombines Ginkgo's robust Concentric by Ginkgo pooled testing program with Quest's PCR/NAAT COVID-19 pooled specimen testing to support return to classroomsGinkgo Bioworks ("Ginkgo") today announced a collaboration with Quest Diagnostics (NYSE:DGX) to provide COVID-19 Kindergarten through Senior (K-12) school testing services to support classroom...
-
04 27 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the BofA Securities 2021 Virtual Healthcare...
-
04 22 2021 -- First quarter revenues of $2.72 billion, up 49.3% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2021. "Quest...
-
04 14 2021 GENEVA--(BUSINESS WIRE)--The Commons Project Foundation and the World Economic Forum today announced the global expansion of the CommonTrust Network (www.commontrustnetwork.org) to cover 32...
-
04 13 2021 10 studies highlight Quest Diagnostics' commitment to specialty genetics testing and research in areas such as mitochondrial mtDNA analysis and next generation sequencingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced today that they will present results of 10 studies at the virtual...
-
04 07 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on Thursday, April...
-
04 01 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading...